Breaking News
Subscribe Now 0
Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 place See list
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
51.86 -0.73    -1.39%
08:32:54 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Austria
ISIN:  US60770K1079 
  • Volume: 15
  • Bid/Ask: 54.02 / 54.24
  • Day's Range: 51.57 - 54.13
Moderna 51.86 -0.73 -1.39%

Moderna Inc Company Profile

 
Get an in-depth profile of Moderna Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

5600

Equity Type

DRC

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address 200 Technology Square
Cambridge, 02139
United States
Phone 617 714 6500
Fax 617 649 3910

Top Executives

Name Age Since Title
Noubar B. Afeyan 60 2010 Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board
Stephane Bancel 50 2011 CEO & Director
Melissa J. Moore - 2016 Member of Scientific Advisory Board
Jack W. Szostak - 2014 Chairman of Scientific Advisory Board
Richard C. Willson - 2014 Member of Technology Advisory Board
Fred E. Regnier - 2014 Member of Technology Advisory Board
John G. Aunins 63 2014 Member of Technology Advisory Board
James R. Swartz - 2014 Member of Technology Advisory Board
Elizabeth G. Nabel 72 2021 Independent Director
Elizabeth Edith Tallett 74 2020 Independent Director
Ulrich H. von Andrian-Werburg - - Member of Scientific Advisory Board
Francois Nader 67 2019 Independent Non Executive Director
Robert S. Langer 75 2010 Member of Scientific Advisory Board
Paula T. Hammond 60 - Member of Scientific Advisory Board
Ron Eydelloth - - Member of Scientific Advisory Board
Paul L. Sagan 65 2018 Independent Non Executive Director
Ralph Weissleder - - Member of Scientific Advisory Board
Sandra J. Horning 75 2020 Independent Director
Rachel Green - - Member of Scientific Advisory Board
Michael Diamond - - Member of Scientific Advisory Board
David Mark Rubenstein 75 2024 Director
Shah Abbas Hussain 59 2024 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRNA Comments

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Matthew Morello
Matthew Morello 3 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cathy Wood dumped 160K shares yesterday. Rut Roh Flavio.
Flavio Man
Flavio Man 14 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You will loose those few pennies left in your checking account. It will be removed from the SP500 at the next earnings and will collapse down to $10.
David Silva
David Silva 4 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lol
Matthew Morello
Matthew Morello Oct 10, 2024 10:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Flav, got the position just about sized to where I want it. Short interest is looking jucy. The squeeze could be a epic 4 day rip.
Babka Dániel
Babka Dániel Oct 10, 2024 6:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
On the board tp 75
Flavio Man
Flavio Man Oct 02, 2024 10:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stay short #to10
Flavio Man
Flavio Man Sep 23, 2024 12:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
joe rubens
joe rubens Sep 20, 2024 11:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Flavio Man
Flavio Man Sep 20, 2024 7:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ignore ezekiel. He is in the wrong forum.
ezekiel kohenoğlu
ezekiel kohenoğlu Sep 20, 2024 5:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I won't listen either of you. please stop being primitive.
Flavio Man
Flavio Man Sep 19, 2024 7:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don’t listen to Morello, he already lost all his savings on this stock
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email